LIBX-A403
Product Specifications
Target
Ferroptosis
Related Pathways
Apoptosis
Bioactivity
LIBX-A403 (Compound 21) is a highly selective inhibitor of acyl-CoA synthetase long-chain family member 4 (ACSL4) with an IC50 of 0.049 μM. It prevents ACSL4-mediated pro-ferroptotic phospholipid remodeling. LIBX-A403 shows potential for research in cancer, such as triple-negative breast cancer, and neurodegenerative disorders like Parkinson's disease.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LS023585-100ug 100 µg
TMEM50A (NM_014313) Human Over-expression Lysate
Sign In for Pricing
View Details 
B0807-09T4-APC 100 µL
Bcl 2 Inhibitor of Transcription 1 (Bit1, Peptidyl-tRNA Hydrolase 2) (APC) discontinued
Sign In for Pricing
View Details MBS6360442-01 0.2 mL
TYROBP, CT (TYROBP, DAP12, KARAP, TYRO protein tyrosine kinase-binding protein, DNAX-activation protein 12, Killer-activating receptor-associated protein) (AP)
Sign In for Pricing
View Details MBS6360442-02 5x 0.2 mL
TYROBP, CT (TYROBP, DAP12, KARAP, TYRO protein tyrosine kinase-binding protein, DNAX-activation protein 12, Killer-activating receptor-associated protein) (AP)
Sign In for Pricing
View Details 
HY-P705108-01 25 µg
VCAM-1/CD106 , Human (Biotinylated, HEK293, Fc-Avi)
Sign In for Pricing
View Details HY-P705108-02 200 µg
VCAM-1/CD106 , Human (Biotinylated, HEK293, Fc-Avi)
Sign In for Pricing
View Details